Involvement of p38 and p42/44 MAP kinases and protein kinase C in the interferon-γ and interleukin-1α-induced phosphorylation of 85-kDa cytosolic phospholipase A2 in primary human bronchial epithelial cells

Cytokine

Volumn 25, Issue 1, 2004, Pages 11-20

  Wu, Tong ^a   Han, Chang ^a   Shelhamer, James H ^b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Interferon ; Interleukin 1; MAP kinase; Phospholipase A2; Protein kinase C

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONIC ACID; BISINDOLYLMALEIMIDE; GAMMA INTERFERON; HALOENOL LACTONE SUICIDE SUBSTRATE; INTERLEUKIN 1ALPHA; LY 311727; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN P44; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; PHOSPHORYLATION; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0347479350     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.08.013     Document Type: Article

References (48)

1. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., Wasserman S.I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 89:1992;958-967.
2. Borish L., Mascali J.J., Dishuck J., Beam W.R., Martin R.J., Rosenwasser L.J. Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol. 149:1992;3078-3082.
3. Cembrzynska-Nowak M., Szklarz E., Inglot A.D., Teodorczyk-Injeyan J.A. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis. 147:1993;291-295.
4. Ackerman V., Marini M., Vittori E., Bellini A., Vassali G., Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest. 105:1994;687-696.
5. Bonfield T.L., Panuska J.R., Konstan M.W., Hilliard K.A., Hilliard J.B., Ghnaim H., et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 152:1995;2111-2118.
6. Maestrelli P., di Stefano A., Occari P., Turato G., Milani G., Pivirotto F., et al. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med. 151:1995;607-612.
7. Krug N., Madden J., Redington A.E., Lackie P., Djukanovic R., Schauer U., et al. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol. 14:1996;319-326.
8. Holtzman M.J., Sampath D., Castro M., Look D.C., Jayaraman S. The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol. 14:1996;316-318.
9. Tillie-Leblond I., Pugin J., Marquette C.H., Lamblin C., Saulnier F., Brichet A., et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med. 159:1999;487-494.
10. Lasky J.A., Brody A.R. Interleukins involved in the pathogenesis of chronic airway inflammation. Res Immunol. 148:1997;39-47.
11. Dery R.E., Bissonnette E.Y. IFN-gamma potentiates the release of TNF-alpha and MIP-1alpha by alveolar macrophages during allergic reactions. Am J Respir Cell Mol Biol. 20:1999;407-412.
12. Wu T., Levine S.J., Lawrence M.G., Logun C., Angus C.W., Shelhamer J.H. Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2. J Clin Invest. 93:1994;571-577.
13. Wu T., Levine S.J., Cowan M., Logun C., Angus C.W., Shelhamer J.H. Antisense inhibition of 85-kDa cPLA2 blocks arachidonic acid release from airway epithelial cells. Am J Physiol. 273:1997;L331-L338.
14. Drazen J.M., Israel E., O'Byrne P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 340:1999;197-206. [published erratum appears in N Engl J Med 1999 Feb 25;340(8):663].
15. Leff A.R. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Respir Crit Care Med. 161:2000;S125-S132.
16. Dahlen S.E., Haeggstrom J.Z., Samuelsson B., Rabe K.F., Leff A.R. Leukotrienes as targets for treatment of asthma and other diseases. Current basic and clinical research [In Process Citation]. Am J Respir Crit Care Med. 161:2000;S1.
17. Wenzel S.E. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy. 17:1997;3S-12S.
18. O'Byrne P.M., Israel E., Drazen J.M. Antileukotrienes in the treatment of asthma. Ann Intern Med. 127:1997;472-480.
19. Bowton D.L., Seeds M.C., Fasano M.B., Goldsmith B., Bass D.A. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med. 155:1997;421-425.
20. Uozumi N., Kume K., Nagase T., Nakatani N., Ishii S., Tashiro F., et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 390:1997;618-622.
21. Peters-Golden M. Pulmonary diseases other than asthma as potential targets for antileukotriene therapy. Clin Rev Allergy Immunol. 17:1999;247-260.
22. Holtzman M.J. Arachidonic acid metabolism. Implications of biological chemistry for lung function and disease. Am Rev Respir Dis. 143:1991;188-203.
23. Holtzman M.J. Arachidonic acid metabolism in airway epithelial cells. Annu Rev Physiol. 54:1992;303-329.
24. Konstan M.W., Walenga R.W., Hilliard K.A., Hilliard J.B. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis. 148:1993;896-901.
25. Zakrzewski J.T., Barnes N.C., Costello J.F., Piper P.J. Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis. 136:1987;779-782.
26. Pickard R.T., Strifler B.A., Kramer R.M., Sharp J.D. Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J Biol Chem. 274:1999;8823-8831.
27. Underwood K.W., Song C., Kriz R.W., Chang X.J., Knopf J.L., Lin L.L. A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2. J Biol Chem. 273:1998;21926-21932.
28. Dennis E.A. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci. 22:1997;1-2.
29. Leslie C.C. Properties and regulation of cytosolic phospholipase A2. J Biol Chem. 272:1997;16709-16712.
30. Channon J.Y., Leslie C.C. A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J Biol Chem. 265:1990;5409-5413.
31. Clark J.D., Lin L.L., Kriz R.W., Ramesha C.S., Sultzman L.A., Lin A.Y., et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043-1051.
32. Kramer R.M., Roberts E.F., Manetta J., Putnam J.E. The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem. 266:1991;5268-5272.
33. Lin L.L., Wartmann M., Lin A.Y., Knopf J.L., Seth A., Davis R.J. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.
34. Nemenoff R.A., Winitz S., Qian N.X., Van Putten V., Johnson G.L., Heasley L.E. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem. 268:1993;1960-1964.
35. Hoeck W.G., Ramesha C.S., Chang D.J., Fan N., Heller R.A. Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci U S A. 90:1993;4475-4479.
36. Nalefski E.A., Sultzman L.A., Martin D.M., Kriz R.W., Towler P.S., Knopf J.L., et al. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J Biol Chem. 269:1994;18239-18249.
37. Gronich J., Konieczkowski M., Gelb M.H., Nemenoff R.A., Sedor J.R. Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J Clin Invest. 93:1994;1224-1233.
38. Winitz S., Gupta S.K., Qian N.X., Heasley L.E., Nemenoff R.A., Johnson G.L. Expression of a mutant Gi2 alpha subunit inhibits ATP and thrombin stimulation of cytoplasmic phospholipase A2-mediated arachidonic acid release independent of Ca2+ and mitogen-activated protein kinase regulation. J Biol Chem. 269:1994;1889-1895.
39. Wu T., Ikezono T., Angus C.W., Shelhamer J.H. Tumor necrosis factor-alpha induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cells. Biochim Biophys Acta. 1310:1996;175-184.
40. Wu T., Angus C.W., Yao X.L., Logun C., Shelhamer J.H. P11, a unique member of the S100 family of calcium-binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2. J Biol Chem. 272:1997;17145-17153.
41. Ikezono T., Wu T., Yao X.L., Levine S., Logun C., Angus C.W., et al. Leukemia inhibitory factor induces the 85-kDa cytosolic phospholipase A2 gene expression in cultured human bronchial epithelial cells. Biochim Biophys Acta. 1355:1997;121-130.
42. Dolan-O'Keefe M., Chow V., Monnier J., Visner G.A., Nick H.S. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am J Physiol Lung Cell Mol Physiol. 278:2000;L649-L657.
43. Hefner Y., Borsch-Haubold A.G., Murakami M., Wilde J.I., Pasquet S., Schieltz D., et al. Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem. 275:2000;37542-37551.
44. Qiu Z.H., Leslie C.C. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J Biol Chem. 269:1994;19480-19487.
45. Kast R., Furstenberger G., Marks F. Phorbol ester TPA- and bradykinin-induced arachidonic acid release from keratinocytes is catalyzed by a cytosolic phospholipase A2 (cPLA2). J Invest Dermatol. 101:1993;567-572.
46. Flati V., Haque S.J., Williams B.R. Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three. EMBO J. 15:1996;1566-1571.
47. Goh K.C., Haque S.J., Williams B.R. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18:1999;5601-5608.
48. Zhou H., Das S., Murthy K.S. Erk1/2- and p38 MAP kinase-dependent phosphorylation and activation of cPLA2 by m3 and m2 receptors. Am J Physiol Gastrointest Liver Physiol. 284:2003;G472-G480.